Brief: Polypid Announces Mid-Stage Study Results For D-Plex₁₀₀

Polypid

19/09/2022 12:09

Sept 19 (Reuters) - PolyPid Ltd  PYPD.O :
    * POLYPID ANNOUNCES PEER-REVIEWED PUBLICATION OF PHASE 2
CLINICAL
TRIAL RESULTS FOR D-PLEX₁₀₀ IN THE PREVENTION OF SURGICAL SITE
INFECTIONS IN ABDOMINAL SURGERY
    * POLYPID ANNOUNCES PEER-REVIEWED PUBLICATION OF PHASE 2
CLINICAL
TRIAL RESULTS FOR D-PLEX₁₀₀ IN THE PREVENTION OF SURGICAL SITE
INFECTIONS IN ABDOMINAL SURGERY
    * POLYPID - INTENDS TO DISCUSS CLINICAL OUTCOMES AND NEXT
STEPS
FOR D-PLEX100 FOR PREVENTION OF SSIS IN ABDOMINAL SURGERY WITH
FDA AND EU IN Q1 2023

Source text for Eikon:  ID:nGNX2WRdlS 
Further company coverage:  PYPD.O 

 ((Reuters.Briefs@thomsonreuters.com;))